Another demonstration of GILZ involvement in the modulation of vascular inflammation is shown in a study conducted in patients with Sjögren’s syndrome, a systemic autoimmune disease of salivary and lacrimal glands, as well as salivary glands of non-obese diabetic mice (a model of Sjögren’s syndrome-like disease). Here, TSC22D3 is linked to Sjogren syndrome.